Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › EGFR/NEDD9/TGF-β interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disorders

EGFR/NEDD9/TGF-β interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disorders

US Patent 10450613 · Granted Oct 22, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor2025
Methods for diagnosis and treatment of patients having solid tumors2023
Treating cancer with a CCK receptor inhibitor and an immune checkpoint inhibitor2022
Systems and methods for treating patients having a genetic predisposition to dev2020
Systems and methods for treating patients having a genetic predisposition to dev2020
C-Myc as a biomarker for tumor sensitivity to treatment with RNA polymerase II i2019
C-Myc as a biomarker for tumor sensitivity to treatment with RNA polymerase II i2019
Method of treating MYC-amplified tumors with RNA-polymerase II inhibitors2018
Methods of inhibiting proliferation of estrogen-independent cancer cells2017
Methods of inhibiting proliferation of estrogen-independent cancer cells2017
Methods of inhibiting proliferation of estrogen-independent cancer cells2017
Combination therapy for the treatment of cancer using an anti-C-met antibody2017